MLTX – Moonlake Immunotherapeutics
Investors holding2
Combined shares539,612
Combined reported value$6.3M
MLTX chart by TradingView. Live prices are TradingView's; all other numbers on this page are from 13F filings.
Ownership
| Investor | % of their portfolio | Change | Shares | Reported value | Period |
|---|---|---|---|---|---|
| Stanley Druckenmiller narrow view | 0.14 | New | 494,000 | $5.8M | Q3 2026 |
| Paul Tudor Jones narrow view | 0.00 | Reduced 22.3% | 45,612 | $534K | Q3 2026 |
Activity: last 4 quarters
| Period | Investor | Change | Shares after | Effect on their portfolio (pts) |
|---|---|---|---|---|
| Q3 2026 | Stanley Druckenmiller narrow view | New | 494,000 | 0.14 |
| Q3 2026 | Paul Tudor Jones narrow view | Reduced 22.3% | 45,612 | 0.00 |
| Q2 2026 | Paul Tudor Jones narrow view | Reduced 4.6% | 58,740 | 0.00 |
| Q1 2026 | Paul Tudor Jones narrow view | Reduced 40.5% | 61,577 | 0.00 |
| Q4 2025 | Paul Tudor Jones narrow view | New | 103,516 | 0.01 |
Added: opened or increased
| Period | Investor | Change | Shares after | Effect on their portfolio (pts) |
|---|---|---|---|---|
| Q3 2026 | Stanley Druckenmiller narrow view | New | 494,000 | 0.14 |
| Q4 2025 | Paul Tudor Jones narrow view | New | 103,516 | 0.01 |
Reduced: reduced or closed
| Period | Investor | Change | Shares after | Effect on their portfolio (pts) |
|---|---|---|---|---|
| Q3 2026 | Paul Tudor Jones narrow view | Reduced 22.3% | 45,612 | 0.00 |
| Q2 2026 | Paul Tudor Jones narrow view | Reduced 4.6% | 58,740 | 0.00 |
| Q1 2026 | Paul Tudor Jones narrow view | Reduced 40.5% | 61,577 | 0.00 |
History
2 peakQ3 2026: 2 tracked investors
20232026
Shares held, last 8 quarters
| Investor | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 |
|---|---|---|---|---|---|---|---|---|
| Stanley Druckenmiller | 494.0K | – | – | – | – | – | – | – |
| Paul Tudor Jones | 45.6K | 58.7K | 61.6K | 103.5K | – | 31.7K | 31.6K | – |
– = not held that quarter. n/a = no holdings report for that quarter (not filed yet, or reported under another manager).